DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Pediatrics
SEARCH
Posição atual:
>
> This Story


Início de uma sessão ou Registo to rate this News Story
Forward Printable StoryPrint Comment
advertisement

 

advertisement

 

Ultrasound Homepage

Handheld ultrasound market poised for next wave of growth Insights from the market analysts at Signify Research

VisualDx to develop decision support platform for ultrasound in space Provide basic guidance on ultrasound interpretation

Breaking barriers in Alzheimer’s disease with focused ultrasound Researchers at Sunnybrook in Toronto are closing the therapeutic gap

Purchasing insights for cardiac ultrasound Guidance from the market experts at MD Buyline

Trice Imaging connects imaging devices of large chain healthcare provider Aleris Patients and physicians can view images on laptops, cell phones

New ultrasound tech could help detect pediatric congenital heart disease Visualizes structure and blood flow of babies' hearts

Getting to the heart of cardiac ultrasound technology From premium systems to point of care, an expanding market

Echocardiogram should play role in patient selection for transcatheter mitral valve repair, says study New study highlighted at ACC

Emerging applications of contrast-enhanced ultrasound in pediatric imaging Discussing the benefits of an emerging technology

Petition calls for removal of 'black box' designation for ultrasound contrast agents Argues that UCAs are safe and "black box" misrepresents risk

Contrast enhanced ultrasound in pediatric patients

From the March 2018 issue of DOTmed HealthCare Business News magazine

Approximately 30 million people in the U.S. have some form of liver disease. However, its symptoms can be vague and easily confused with other health complications, making it difficult to diagnose.

In April 2016, the FDA approved the use of contrast agent for liver lesion characterization in adult and pediatric patients, offering clinicians a fast way of confidently detecting problems in a patient’s liver, using non-ionizing radiation.
Story Continues Below Advertisement

THE (LEADER) IN MEDICAL IMAGING TECHNOLOGY SINCE 1982. SALES-SERVICE-REPAIR

Special-Pricing Available on Medical Displays, Patient Monitors, Recorders, Printers, Media, Ultrasound Machines, and Cameras.This includes Top Brands such as SONY, BARCO, NDS, NEC, LG, EDAN, EIZO, ELO, FSN, PANASONIC, MITSUBISHI, OLYMPUS, & WIDE.




Our main clinical indication for contrast enhanced ultrasound (CEUS) is to characterize focal liver lesions. Focal liver lesions occur in about 17 percent of children after cancer therapy. When such lesions arise, it is crucial to determine whether they are benign or represent metastatic disease. Before utilizing CEUS at our institution, such patients would undergo additional imaging (often MRI which can require sedation of young patients) or early imaging follow-up to determine the growth rate of the lesion. This approach resulted in added time, cost and anxiety in the patient’s management.



Now these patients undergo CEUS on the same day or the next day after the original imaging exam that discovered the focal liver lesion. This approach is quick, low-cost, uses non-ionizing radiation and is sedation-free. It provides immediate clinical images, which enables physicians to give feedback to the patient, their family and treating physician.

I believe the role of CEUS in pediatric oncology will increase. There are a wide variety of potential applications. In addition to being low-cost and sedation-free, it has the added benefit of being portable. This is an important attribute in our institution because patients needing imaging studies may be too ill to come to the radiology department. The system can be easily transported to their bedside. Children are naturally in motion, so it’s important to be able to capture clear images quickly.

With the introduction of targeted therapies into cancer clinical trials, there is a growing need for functional and metabolic imaging methods that go beyond a simple measurement of tumor size. Dynamic, quantitative contrast enhanced ultrasound may provide a method of assessing tumor blood flow which, in turn, may reflect or predict response to therapy.
Dr. Beth McCarville
This, however, needs to be validated in clinical trials.

About the author: Dr. Beth McCarville is the chief of the Body Imaging Section at St. Jude Children’s Research Hospital.

Back to HCB News
<< Pages: 1 - 2

Ultrasound Homepage


You Must Be Logged In To Post A Comment

Anuncie
Aumente a Sua Perceção da Marca
Leilões + Vendas Privadas
Comece
O mais melhor preço
Comprar Equipamento/Peças
Encontre
O preço o mais baixo
Notícia diária
Leia
A notícia a mais atrasada
Diretório
Browse tudo
DOTmed Usuários
Ética no DOTmed
Veja o nosso
Programa das éticas
O ouro parte o programa do vendedor
Receba PH
Pedidos
Programa do negociante do serviço do ouro
Receba RFP/PS
Pedidos
Fornecedores de Healthcare
Veja tudo
Ferramentas de HCP
Trabalhos/Treinamento
Achado/suficiência
Um trabalho
Parts Hunter +EasyPay
Comece as peças
Citações
Certificado recentemente
Vista recentemente
Usuários certificados
Recentemente Rated
Vista recentemente
Usuários certificados
Central Rental
Equipamento do aluguel
Para menos
Vender Equipamentos/Peças
Comece
A maioria de dinheiro
Preste serviços de manutenção ao Forum dos técnicos
Ajuda do achado
E conselho
Simples RFP
Comece o equipamento
Citações
Mostra de comércio virtual
Serviço do achado
Para o equipamento
O acesso e o uso deste local são sujeitos aos termos e às condições do nosso OBSERVAÇÃO LEGAL & OBSERVAÇÃO DA PRIVACIDADE
Propriedade de e proprietário DOTmeda .com, Inc. Copyright ©2001-2019 DOTmed.com, Inc.
TODOS OS DIREITOS RESERVADOS